
Sino Biological/SARS-CoV-2 (2019-nCoV) Spike S1 Antibody, Rabbit MAb/1/40150-R007
商品编号:
40150-R007
品牌:
sinobiological
市场价:
¥0.00
美元价:
0.00
联系Q Q:
3392242852
电话号码:
4000-520-616
电子邮箱:
info@ebiomall.com
商品介绍
SARS-CoV-2 (2019-nCoV) Spike S1 Antibody, Rabbit MAb General Information
Product name
SARS-CoV-2 (2019-nCoV) Spike S1 Antibody, Rabbit MAb
Validated applications
ELISA
Application notes
IHC, FCM, IF, IP et al. applications haven"t been validated.(Antibody"s applications haven"t been validated with corresponding virus positive samples. Optimal concentrations/dilutions should be determined by the end user.)
Specificity
SARS Coronavirus spikeNo cross-reactivity in ELISA withMERS-CoV Spike S1 Protein (Cat# 40069-V08B1)HCoV-HKU1 (isolate N1) Spike S1 Protein (Cat# 40021-V08H)HCoV-HKU1 (isolate N5) Spike S1 Protein (Cat# 40602-V08H)HCoV-NL63 Spike S1 Protein (Cat# 40600-V08H)HCoV-229E Spike S1 Protein (Cat# 40601-V08H)HCoV-OC43 Spike S1+S2 ECD Protein (Cat# 40607-V08B)
Preparation
This product is a recombinant monoclonal antibody expressed from HEK293 cells.
Source
Monoclonal Rabbit IgG Clone #007
Purification
Protein A
Formulation
0.2 μm filtered solution in PBS
Conjugate
Unconjugated
Form
Liquid
Shipping
This antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Storage
This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles.
SARS-CoV-2 (2019-nCoV) Spike S1 Antibody, Rabbit MAb Validated Applications
Application | Dilution |
---|---|
ELISA | 1:5000-1:10000 |
Please Note: Optimal concentrations/dilutions should be determined by the end user.
SARS-CoV-2 (2019-nCoV) Spike S1 Antibody, Rabbit MAb Images

Immunofluorescence staining of SARS-CoV-2 (2019-nCoV) Spike in ACE2-overexpressed 293T cells, infected (left) or noninfected (right) by 2019-nCOV-Spike pseudovirus (PSV). Cells were blocked with 10% serum, and incubated with SARS-CoV-2 (2019-nCoV) Spike rabbit monoclonal antibody(dilution ratio 1:60) at 37℃ for 1 hour. Then cells were stained with the Alexa Fluor®-conjugated Goat Anti-rabbit IgG secondary antibody(green).
SARS-CoV-2 (2019-nCoV) Spike S1 Antibody, Rabbit MAb: Synonyms
Anti-coronavirus s1 Antibody; Anti-coronavirus s2 Antibody; Anti-coronavirus spike Antibody; Anti-cov spike Antibody; Anti-ncov RBD Antibody; Anti-ncov s1 Antibody; Anti-ncov s2 Antibody; Anti-ncov spike Antibody; Anti-novel coronavirus RBD Antibody; Anti-novel coronavirus s1 Antibody; Anti-novel coronavirus s2 Antibody; Anti-novel coronavirus spike Antibody; Anti-RBD Antibody; Anti-S1 Antibody; Anti-s2 Antibody; Anti-Spike RBD Antibody
Coronavirus spike Background Information
The spike (S) glycoprotein of coronaviruses contains protrusions that will only bind to certain receptors on the host cell. Known receptors bind S1 are ACE2, angiotensin-converting enzyme 2; DPP4, dipeptidyl peptidase-4; APN, aminopeptidase N; CEACAM, carcinoembryonic antigen-related cell adhesion molecule 1; Sia, sialic acid; O-ac Sia, O-acetylated sialic acid. The spike is essential for both host specificity and viral infectivity. The term "peplomer" is typically used to refer to a grouping of heterologous proteins on the virus surface that function together. The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. It"s been reported that SARS-CoV-2 (COVID-19 coronavirus, 2019-nCoV) can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. The main functions for the Spike protein are summarized as: Mediate receptor binding and membrane fusion; Defines the range of the hosts and specificity of the virus; Main component to bind with the neutralizing antibody; Key target for vaccine design; Can be transmitted between different hosts through gene recombination or mutation of the receptor binding domain (RBD), leading to a higher mortality rate.
References
- Shen S, et al. (2007) Expression, glycosylation, and modification of the spike (S) glycoprotein of SARS CoV. Methods Mol Biol. 379: 127-35.
- Du L, et al. (2009) The spike protein of SARS-CoV--a target for vaccine and therapeutic development. Nat Rev Microbiol. 7 (3): 226-36.
- Xiao X, et al. (2004) The SARS-CoV S glycoprotein. Cell Mol Life Sci. 61 (19-20): 2428-30.
- Lectin-like Intestinal Defensin Inhibits 2019-nCoV Spike binding to ACE2AuthorWang, C;Wang, S;Li, D;Zhao, X;Han, S;Wang, T;Zhao, G;Year2020JournalbioRxivFoldedExpand
- Rapid Detection of COVID-19 Causative Virus (SARS-CoV-2) in Human Nasopharyngeal Swab Specimens Using Field-Effect Transistor-Based BiosensorAuthorSeo, G;Lee, G;Kim, MJ;Baek, SH;Choi, M;Ku, KB;Lee, CS;Jun, S;Park, D;Kim, HG;Kim, SJ;Lee, JO;Kim, BT;Park, EC;Kim, SI;Year2020JournalACS NanoPubMed ID: 32293168FoldedExpand
- SARS-CoV-2 invades host cells via a novel route: CD147-spike proteinAuthorWang, K;Chen, W;Zhou, YS;Lian, JQ;Zhang, Z;Du, P;Year2020JournalbioRxivApplicationIP, ELISA, EMFoldedExpand
- 上海 2 株严重急性呼吸综合征冠状病毒 2 的分离与鉴定Author彭浩然, ;李成忠, ;唐海琳, ;薛建亚, ;陈志辉, ;梁雪松, ;朱咏梅, ;夏炳辉, ;朱勇喆, ;吴俊杰, ;赵兰娟, ;任浩, ;江亮亮, ;何燕华, ;戚中田, ;赵平, ;Year2020Journal第二军医大学学报ApplicationIFFoldedExpand
- SARS-CoV-2 growth, furin-cleavage-site adaptation and neutralization using serum from acutely infected, hospitalized COVID-19 patientsAuthorKlimstra, W;Tilston-Lunel, N;Nambulli, S;Boslett, J;McMillen, C;Gilliland, T;Dunn, M;Sun, C;Wheeler, S;Wells, A;Hartman, A;McElroy, A;Reed, D;Rennick, L;Duprex, W;Year2020JournalbioRxivApplicationIFFoldedExpand
- Clinical and pathological findings of SARS-CoV-2 infection and concurrent IgA nephropathy: A case reportAuthorLiu, L;Year2020JournalResearch SquareApplicationIHCFoldedExpand
- Unlocking the lockdown of science and demystifying COVID-19: how autopsies contribute to our understanding of a deadly pandemicAuthorTzankov, A;Jonigk, D;Year2020JournalVirchows Arch.ApplicationIHCPubMed ID: 32648040FoldedExpand
- Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcomeAuthorpandolfi, l;Tommaso, F;Vanessa, F;Sara, B;Monica, M;Maura, D;Sara, L;Mario, U;Alessandro, D;Laura, S;Elena, P;Stefano, T;Lorenzo, C;Emanuela, C;Francesco, M;Paola, B;Davide, O;Daniele, L;Guido, C;Eloisa, A;Riccardo, C;Federica, M;Year2020JournalResearch SquareFoldedExpand
- Human Mesenchymal Stromal Cells are resistant to SARS-CoV-2 Infection under Steady State, Inflammatory Conditions and in the Presence of SARS-CoV-2 infected CellsAuthorSchäfer, R;Spohn, G;Bechtel, M;Bojkova, D;Baer, P;Kuçi, S;Seifried, E;Ciesek, S;Cinatl, J;Year2020JournalStem Cell ReportsFoldedExpand
- Screening Antibodies Raised Against the Spike Glycoprotein of SARS-CoV-2 to Support the Development of Rapid Antigen AssaysAuthorCantera, J;Cate, D;Golden, A;Peck, R;Lillis, L;Domingo, G;Murphy, E;Barnhart, B;Anderson, C;Alonzo, L;Glukhova, V;Hermansky, G;Barrios-Lopez, B;Spencer, E;Kuhn, S;Islam, Z;Grant, B;Kraft, L;Herve, K;de Puyraimond, V;Hwang, Y;Dewan, P;Weigl, B;Nichols, K;Boyle, D;Year2020JournalChemRxivFoldedExpand
If you couldn"t find the specific citation, you can:
- Find All Citations
- Submit a CitationGet a Publication Reward
- Leave Us a Message
Recombinant Antibody Production Service
High-throughput Recombinant Antibody Production
Large-scale Antibody Production
Antibody Development Service
Rabbit MAb Production Service
Mouse MAb Production Service
Rabbit PAb Production Service
Phospho-Specific Antibody
Anti-Idiotype Antibody
Fast Antibody Development Service
Mouse MAb
Rabbit PAb
More Antibody Production Service
Hybridoma Antibody Production
Chimeric Antibody
Antibody Fragment
Bispecific Antibody
We also have Immunoassay Service. Click to see more.
品牌介绍
北京义翘神州科技股份有限公司(Sino Biological Inc.)是一家从事生物试剂研发、生产、销售并提供技术服务的生物科技公司,主要业务包括重组蛋白、抗体、基因和培养基等产品,以及重组蛋白、抗体的开发和生物分析检测等服务。义翘神州为全球的药品研发企业和生命科学研究机构提供高质量的生物试剂产品和高水平的技术服务。公司目前生产和销售的现货产品种类超过 4.6 万种,其中重组蛋白约 6,000 种,包括超过 3,800 种人源细胞表达重组蛋白产品,能够全面满足客户对于最接近人体天然蛋白结构和性质的重组蛋白需求;公司还能提供约 12,000 种抗体,其中单克隆抗体数量约 4,600 种,能够覆盖生命科学研究的多个领域,为分子生物学、细胞生物学、免疫学、发育生物学、干细胞研究等基础科研方向和创新药物研发提供「一站式」生物试剂产品和技术服务。义翘神州的客户涵盖大学、科研院所、医药研发企业等国内外各类生物研发单位。目前公司已经在美国、欧洲建立了子公司,已成为生物试剂行业国内领先的科技公司之一。
联络我们